191 related articles for article (PubMed ID: 18499211)
21. Xenoinfection of nonhuman primates by feline immunodeficiency virus.
Johnston JB; Olson ME; Rud EW; Power C
Curr Biol; 2001 Jul; 11(14):1109-13. PubMed ID: 11509233
[TBL] [Abstract][Full Text] [Related]
22. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
[TBL] [Abstract][Full Text] [Related]
23. Failure of FIV-infected cats to control Toxoplasma gondii correlates with reduced IL2, IL6, and IL12 and elevated IL10 expression by lymph node T cells.
Levy JK; Liang Y; Ritchey JW; Davidson MG; Tompkins WA; Tompkins MB
Vet Immunol Immunopathol; 2004 Mar; 98(1-2):101-11. PubMed ID: 15127847
[TBL] [Abstract][Full Text] [Related]
24. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage.
Diehl LJ; Mathiason-Dubard CK; O'Neil LL; Obert LA; Hoover EA
J Virol; 1995 Oct; 69(10):6149-57. PubMed ID: 7666517
[TBL] [Abstract][Full Text] [Related]
25. Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.
Eckstrand CD; Hillman C; Smith AL; Sparger EE; Murphy BG
PLoS One; 2016; 11(1):e0146285. PubMed ID: 26741651
[TBL] [Abstract][Full Text] [Related]
26. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence.
Afkhami-Goli A; Liu SH; Zhu Y; Antony JM; Arab H; Power C
J Neurovirol; 2009 Apr; 15(2):139-52. PubMed ID: 19115133
[TBL] [Abstract][Full Text] [Related]
27. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
28. Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies.
Willett BJ; Kraase M; Logan N; McMonagle E; Varela M; Hosie MJ
PLoS One; 2013; 8(1):e54871. PubMed ID: 23372784
[TBL] [Abstract][Full Text] [Related]
29. Acute virulent infection with feline immunodeficiency virus (FIV) results in lymphomagenesis via an indirect mechanism.
Magden E; Miller C; MacMillan M; Bielefeldt-Ohmann H; Avery A; Quackenbush SL; Vandewoude S
Virology; 2013 Feb; 436(2):284-94. PubMed ID: 23290868
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral latency in peripheral CD4+ T cells isolated from feline immunodeficiency virus-infected cats during the asymptomatic phase is not associated with hypermethylation of the proviral promoter.
Murphy B; Hillman C; Mok M; Vapniarsky N
Virus Res; 2012 Oct; 169(1):117-26. PubMed ID: 22846918
[TBL] [Abstract][Full Text] [Related]
31. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.
Yang JS; English RV; Ritchey JW; Davidson MG; Wasmoen T; Levy JK; Gebhard DH; Tompkins MB; Tompkins WA
J Virol; 1996 May; 70(5):3011-7. PubMed ID: 8627777
[TBL] [Abstract][Full Text] [Related]
32. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.
Bishop SA; Williams NA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
AIDS; 1992 Mar; 6(3):287-93. PubMed ID: 1348945
[TBL] [Abstract][Full Text] [Related]
33. Early events in the immunopathogenesis of feline retrovirus infections.
Tompkins MB; Nelson PD; English RV; Novotney C
J Am Vet Med Assoc; 1991 Nov; 199(10):1311-5. PubMed ID: 1666073
[TBL] [Abstract][Full Text] [Related]
34. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
[TBL] [Abstract][Full Text] [Related]
35. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.
Ackley CD; Yamamoto JK; Levy N; Pedersen NC; Cooper MD
J Virol; 1990 Nov; 64(11):5652-5. PubMed ID: 1976826
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of the plasma globulin level, CD21(-) B-cell counts and FOXP3 mRNA expression level in CD4(+) T-cells for different clinical stages of feline immunodeficiency virus infected cats.
Takano T; Hosoya S; Shibao A; Nagasaki B; Yoshioka H; Satoh R; Hohdatsu T
Res Vet Sci; 2012 Feb; 92(1):157-61. PubMed ID: 21074227
[TBL] [Abstract][Full Text] [Related]
37. Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.
Hosie MJ; Willett BJ; Klein D; Dunsford TH; Cannon C; Shimojima M; Neil JC; Jarrett O
J Virol; 2002 Jun; 76(12):6062-72. PubMed ID: 12021339
[TBL] [Abstract][Full Text] [Related]
38. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus.
Burkhard MJ; Obert LA; O'Neil LL; Diehl LJ; Hoover EA
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):347-55. PubMed ID: 9071435
[TBL] [Abstract][Full Text] [Related]
39. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus.
Bucci JG; English RV; Jordan HL; Childers TA; Tompkins MB; Tompkins WA
J Infect Dis; 1998 Jan; 177(1):18-25. PubMed ID: 9419165
[TBL] [Abstract][Full Text] [Related]
40. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.
Power C; Buist R; Johnston JB; Del Bigio MR; Ni W; Dawood MR; Peeling J
J Virol; 1998 Nov; 72(11):9109-15. PubMed ID: 9765456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
